BeiGene, Ltd.
ONC
$221.89
$1.940.88%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -6.00% | 15.83% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.00% | 15.83% | |||
| Cost of Revenue | -4.63% | 0.85% | |||
| Gross Profit | -6.23% | 18.84% | |||
| SG&A Expenses | -13.55% | 12.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -198.08% | |||
| Total Operating Expenses | -12.46% | 8.12% | |||
| Operating Income | 114.80% | 47.40% | |||
| Income Before Tax | 131.84% | 51.10% | |||
| Income Tax Expenses | -73.50% | 343.50% | |||
| Earnings from Continuing Operations | 100.91% | 7.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 100.91% | 7.44% | |||
| EBIT | 114.80% | 47.40% | |||
| EBITDA | 228.51% | 72.13% | |||
| EPS Basic | 100.91% | 8.56% | |||
| Normalized Basic EPS | 135.53% | 50.97% | |||
| EPS Diluted | 100.87% | 8.56% | |||
| Normalized Diluted EPS | 134.18% | 50.97% | |||
| Average Basic Shares Outstanding | 0.63% | 1.23% | |||
| Average Diluted Shares Outstanding | 4.62% | 1.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||